Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
4.26B | 3.86B | 2.93B | 1.74B | 7.39B | Gross Profit |
1.57B | 829.30M | 0.00 | -1.16B | 2.35B | EBIT |
46.50M | 153.90M | 122.80M | 224.30M | -152.70M | EBITDA |
656.30M | 896.70M | 875.40M | 1.15B | 697.80M | Net Income Common Stockholders |
-15.90M | 87.10M | 636.40M | 78.40M | -327.20M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
496.50M | 791.40M | 787.70M | 1.44B | 237.10M | Total Assets |
3.81B | 4.41B | 3.83B | 8.29B | 8.34B | Total Debt |
1.63B | 2.07B | 1.41B | 3.82B | 4.20B | Net Debt |
1.13B | 1.28B | 626.10M | 2.38B | 3.96B | Total Liabilities |
3.17B | 3.66B | 2.95B | 7.14B | 7.17B | Stockholders Equity |
633.30M | 740.20M | 876.60M | 1.18B | 1.21B |
Cash Flow | Free Cash Flow | |||
324.00M | 395.90M | -186.20M | 814.80M | 627.20M | Operating Cash Flow |
543.30M | 573.80M | 65.40M | 1.20B | 958.20M | Investing Cash Flow |
-10.20M | 79.40M | 2.08B | -270.00M | -303.40M | Financing Cash Flow |
-776.30M | -640.90M | -2.89B | -357.90M | -481.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $35.20B | 32.24 | 10.62% | 0.41% | 5.21% | 24.15% | |
73 Outperform | $2.19B | 16.53 | 14.14% | 4.32% | -9.40% | 8.41% | |
70 Neutral | $204.85M | 5.88 | 23.08% | ― | -8.75% | 354.10% | |
69 Neutral | $1.44B | 12.66 | 14.33% | 2.48% | 5.76% | 304.12% | |
67 Neutral | $1.49B | 7.51 | 14.69% | 2.57% | -5.79% | 82.71% | |
64 Neutral | $4.44B | 11.99 | 5.16% | 249.23% | 4.01% | -11.87% | |
52 Neutral | $143.56M | ― | 156.43% | ― | 12.58% | 34.10% |